跳至主要内容
临床试验/NCT02018094
NCT02018094已完成4 期

A Randomised Control Trial to Determine Whether a 5 Day Course of Antibiotics is More Clinically and Cost Effective Than a 24 Hour Prophylactic Course for the Prevention of Surgical Site Infection Following Lower Limb Amputation

Hull University Teaching Hospitals NHS Trust1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2013年10月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
160
试验地点
1
主要终点
Surgical Site Infection

研究概览

简要总结

  • Lower limb amputations are performed usually as a last resort in patients with acute and chronic limb ischaemia (CLI) caused by vascular disease, poorly controlled diabetes or, infection.
  • In the period 2003-2008 there were approximately 5,000 amputations per year in the UK.
  • The Centre for Disease Control defines a Surgical Site Infection (SSI) as an infection within 30 days of an operation or up to one year if an implant is left in place and the infection is related to an operative procedure.
  • Figures from the Surgical Site Infection Surveillance reported that the highest rate of surgical site infection was reported in association with lower limb amputation at 13.1%.
  • There is a clear under-representation and the infection rate within our institution is approximately 25% which reflects the infection rate reported in a recent trial by Sadat et al (22.5%)
  • Prevention of surgical site infections is of paramount importance to patients, healthcare providers and policy-makers, as they impact on morbidity and mortality and have significant time and cost implications.
  • Currently there is NO CONSENSUS as to what the best practice is towards antibiotic administration in such patients. From a questionnaire-based audit we performed including vascular departments across the entire country, practice varies in both course duration (single dose → 5 days antibiotic course) as well as choice of antibiotics.
  • The guideline at our institution suggests the 5-day course of antibiotic prophylaxis. The course duration varies depending on the clinical picture as well as microbiology results and recommendations.
  • There are no randomised control trials that have investigated this aspect of patient care. We have set up one such trial and through it, we are looking to establish a standard practice which will hopefully be as beneficial as possible to the patient but also cost-effective for NHS.

详细描述

As above

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥18 yrs undergoing lower limb amputations who are able to consent to the trial.
  • Able to understand the Patient Information Sheet and capable and willing to give informed consent and follow the protocol requirements (including attending all follow-up visits)

排除标准

  • Allergies to chlorhexidine/ alcohol/ iodophors
  • Inability to give informed consent
  • Patients who are admitted to hospital with severe sepsis secondary to gas gangrene requiring multiple operations and admission to Intensive Care Unit.
  • Aged under 18 years at the time of recruitment
  • Use of investigational drug/device therapy within preceding 4 weeks that may interfere with this study.
  • Toe amputations

研究组 & 干预措施

24 hour antibiotic course

Active Comparator

24 hours of the stated antibiotics administered intravenously (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function)

干预措施: Co-amoxiclav (Drug)

24 hour antibiotic course

Active Comparator

24 hours of the stated antibiotics administered intravenously (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function)

干预措施: Iodine (Drug)

24 hour antibiotic course

Active Comparator

24 hours of the stated antibiotics administered intravenously (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function)

干预措施: Metronidazole (Drug)

24 hour antibiotic course

Active Comparator

24 hours of the stated antibiotics administered intravenously (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function)

干预措施: Chlorhexidine (Drug)

24 hour antibiotic course

Active Comparator

24 hours of the stated antibiotics administered intravenously (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function)

干预措施: Teicoplanin (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Co-amoxiclav (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Iodine (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Metronidazole (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Chlorhexidine (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Teicoplanin (Drug)

5 day antibiotic Course

Active Comparator

24 hours of IV antibiotics followed by 4 days of oral antibiotics (Augmentin and metronidazole. Teicoplanin and or gentamicin will be used if penicillin allergic and state of renal function. Clindamycin will be used as a an oral replacement for penicillin allergic patients)

干预措施: Clindamycin (Drug)

Iodine

Active Comparator

Skin Preparation used pre-operatively: Alcoholic Povidone

干预措施: Co-amoxiclav (Drug)

Iodine

Active Comparator

Skin Preparation used pre-operatively: Alcoholic Povidone

干预措施: Iodine (Drug)

Iodine

Active Comparator

Skin Preparation used pre-operatively: Alcoholic Povidone

干预措施: Metronidazole (Drug)

Iodine

Active Comparator

Skin Preparation used pre-operatively: Alcoholic Povidone

干预措施: Teicoplanin (Drug)

Iodine

Active Comparator

Skin Preparation used pre-operatively: Alcoholic Povidone

干预措施: Clindamycin (Drug)

Chlorhexidine

Active Comparator

Skin preparation to be used preoperatively: Alcoholic chlorhexidine

干预措施: Co-amoxiclav (Drug)

Chlorhexidine

Active Comparator

Skin preparation to be used preoperatively: Alcoholic chlorhexidine

干预措施: Metronidazole (Drug)

Chlorhexidine

Active Comparator

Skin preparation to be used preoperatively: Alcoholic chlorhexidine

干预措施: Chlorhexidine (Drug)

Chlorhexidine

Active Comparator

Skin preparation to be used preoperatively: Alcoholic chlorhexidine

干预措施: Teicoplanin (Drug)

Chlorhexidine

Active Comparator

Skin preparation to be used preoperatively: Alcoholic chlorhexidine

干预措施: Clindamycin (Drug)

结局指标

主要结局

Surgical Site Infection

时间窗: 30 days

Primary objective: to establish the effect of 5 days of antibiotics versus a 24-hour prophylactic course on the incidence of surgical site infection (SSI) - total ASEPSIS score \>21

次要结局

  • Pain Control(1 year)
  • Mobility(1 year)
  • Satisfactory healing rates(3 months)
  • Resource use(up to 3 months)
  • Quality of life Questionnaire(1 year)
  • Rate of C. Diff., MSSA (Methicillin Sensitive Staphylococcus Aureus), MRSA (Methicillin Resistant Staphylococcus Aureus) infection(30 days)
  • Rate of re-intervention(30 days)
  • Mortality(1 year)
  • Impact of different skin preparations on infection rates(30 days)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验